Cassava Sciences, Inc. (SAVA)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cassava Sciences, Inc. (“Cassava” or “the Company”) (NASDAQ: SAVA). Investors who purchased Cassava securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Cassava has violated federal securities laws.
Investigation Details:
On October 12, 2023, Science reported that Professor Hoau-Yan Wang, a CUNY researcher associated with the research program for Cassava’s Alzheimer’s drug candidate simufilam, had been investigated by university officials for possible data manipulation. Although the investigative committee did not have access to the raw data at issue and thus was unable to confirm that data manipulation had occurred, members made their conclusion based on “long-standing and egregious misconduct in data management and record keeping by Dr. Wang” and “found evidence highly suggestive of deliberate scientific misconduct” by Wang. On this news, Cassava’s stock price fell $2.68 per share, or 15.28%, to close at $14.86 per share on October 13, 2023.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Cassava securities, you can assist this investigation. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman:
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]
